2024 ICD-10-CM Diagnosis Code T38.7X1A

Poisoning by androgens and anabolic congeners, accidental (unintentional), initial encounter

ICD-10-CM Code:
T38.7X1A
ICD-10 Code for:
Poisoning by androgens and anabolic congeners, acc, init
Is Billable?
Yes - Valid for Submission
Chronic Condition Indicator: [1]
Not chronic
Code Navigator:

Code Classification

  • Injury, poisoning and certain other consequences of external causes
    (S00–T88)
    • Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances
      (T36-T50)
      • Poisoning by, adverse effect of and underdosing of hormones and their synthetic substitutes and antagonists, not elsewhere classified
        (T38)

T38.7X1A is a billable diagnosis code used to specify a medical diagnosis of poisoning by androgens and anabolic congeners, accidental (unintentional), initial encounter. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024.

T38.7X1A is an initial encounter code, includes a 7th character and should be used while the patient is receiving active treatment for a condition like poisoning by androgens and anabolic congeners accidental (unintentional). According to ICD-10-CM Guidelines an "initial encounter" doesn't necessarily means "initial visit". The 7th character should be used when the patient is undergoing active treatment regardless if new or different providers saw the patient over the course of a treatment. The appropriate 7th character codes should also be used even if the patient delayed seeking treatment for a condition.

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Accidental methandriol overdose
  • Accidental methandriol poisoning
  • Accidental nandrolone overdose
  • Accidental nandrolone poisoning
  • Accidental oxymetholone overdose
  • Accidental oxymetholone poisoning
  • Accidental testosterone overdose
  • Accidental testosterone poisoning
  • Anabolic steroid overdose
  • Anabolic steroid poisoning
  • Androgen overdose
  • Androgen poisoning
  • Methandriol overdose
  • Nandrolone overdose
  • Oxymetholone overdose
  • Poisoning by methandriol
  • Poisoning by nandrolone
  • Poisoning by oxymetholone
  • Poisoning by testosterone
  • Testosterone overdose

Clinical Classification

Clinical CategoryCCSR Category CodeInpatient Default CCSROutpatient Default CCSR
External cause codes: intent of injury, accidental/unintentionalEXT020N - Not default inpatient assignment for principal diagnosis or first-listed diagnosis.N - Not default outpatient assignment for principal diagnosis or first-listed diagnosis.
External cause codes: poisoning by drugEXT014N - Not default inpatient assignment for principal diagnosis or first-listed diagnosis.N - Not default outpatient assignment for principal diagnosis or first-listed diagnosis.
Poisoning by drugs, initial encounterINJ022Y - Yes, default inpatient assignment for principal diagnosis or first-listed diagnosis.Y - Yes, default outpatient assignment for principal diagnosis or first-listed diagnosis.

Clinical Information

  • Androsterone

    a metabolite of testosterone or androstenedione with a 3-alpha-hydroxyl group and without the double bond. the 3-beta hydroxyl isomer is epiandrosterone.
  • Glucuronosyltransferase

    a family of enzymes accepting a wide range of substrates, including phenols, alcohols, amines, and fatty acids. they function as drug-metabolizing enzymes that catalyze the conjugation of udpglucuronic acid to a variety of endogenous and exogenous compounds. ec 2.4.1.17.
  • Ethylestrenol

    an anabolic steroid with some progestational activity and little androgenic effect.
  • Norethandrolone

    a synthetic hormone with anabolic and androgenic properties and moderate progestational activity.
  • Fluoxymesterone

    an anabolic steroid that has been used in the treatment of male hypogonadism, delayed puberty in males, and in the treatment of breast neoplasms in women.
  • Mesterolone

    17 beta-hydroxy-1 alpha-methyl-5 alpha-androstan-3-one. a synthetic steroid with anabolic and androgenic activities.
  • Methandriol

    a synthetic steroid with anabolic and androgenic properties. (from martindale, the extra pharmacopoeia, 30th ed, p1188)
  • Methandrostenolone

    a synthetic steroid with anabolic properties that are more pronounced than its androgenic effects. it has little progestational activity. (from martindale, the extra pharmacopoeia, 30th ed, p1188)
  • Methenolone

    a synthetic steroid that has been used for its anabolic action.
  • Methyltestosterone

    a synthetic hormone used for androgen replacement therapy and as an hormonal antineoplastic agent (antineoplastic agents, hormonal).
  • Nandrolone

    c18 steroid with androgenic and anabolic properties. it is generally prepared from alkyl ethers of estradiol to resemble testosterone but less one carbon at the 19 position.
  • Nandrolone Decanoate

    decanoic acid ester of nandrolone that is used as an anabolic agent to prevent or treat wasting syndrome associated with severe chronic illness or hiv infection (hiv wasting syndrome). it may also be used in the treatment of postmenopausal osteoporosis.
  • Oxandrolone

    a synthetic hormone with anabolic and androgenic properties.
  • Oxymetholone

    a synthetic hormone with anabolic and androgenic properties. it is used mainly in the treatment of anemias. according to the fourth annual report on carcinogens (ntp 85-002), this compound may reasonably be anticipated to be a carcinogen. (from merck index, 11th ed)
  • Stanozolol

    a synthetic steroid that has anabolic and androgenic properties. (from martindale, the extra pharmacopoeia, 30th ed, p1194)
  • Testolactone

    an antineoplastic agent that is a derivative of progesterone and used to treat advanced breast cancer.
  • 17-Hydroxysteroid Dehydrogenases

    a class of enzymes that catalyzes the oxidation of 17-hydroxysteroids to 17-ketosteroids. ec 1.1.-.
  • 3-Oxo-5-alpha-Steroid 4-Dehydrogenase

    an enzyme that catalyzes the reduction of testosterone to 5-alpha dihydrotestosterone.
  • 5-alpha Reductase Inhibitors

    drugs that inhibit 3-oxo-5-alpha-steroid 4-dehydrogenase. they are commonly used to reduce the production of dihydrotestosterone.
  • Clusterin

    a highly conserved heterodimeric glycoprotein that is differentially expressed during many severe physiological disturbance states such as cancer; apoptosis; and various neurological disorders. clusterin is ubiquitously expressed and appears to function as a secreted molecular chaperone.
  • Receptors, Androgen

    proteins, generally found in the cytoplasm, that specifically bind androgens and mediate their cellular actions. the complex of the androgen and receptor migrates to the cell nucleus where it induces transcription of specific segments of dna.
  • Sex Hormone-Binding Globulin

    a glycoprotein migrating as a beta-globulin. its molecular weight, 52,000 or 95,000-115,000, indicates that it exists as a dimer. the protein binds testosterone, dihydrotestosterone, and estradiol in the plasma. sex hormone-binding protein has the same amino acid sequence as androgen-binding protein. they differ by their sites of synthesis and post-translational oligosaccharide modifications.
  • Steroid 16-alpha-Hydroxylase

    a liver microsomal cytochrome p450 enzyme that catalyzes the 16-alpha-hydroxylation of a broad spectrum of steroids, fatty acids, and xenobiotics in the presence of molecular oxygen and nadph-ferrihemoprotein reductase. this enzyme is encoded by a number of genes from several cyp2 subfamilies.
  • Testosterone

    a potent androgenic steroid and major product secreted by the leydig cells of the testis. its production is stimulated by luteinizing hormone from the pituitary gland. in turn, testosterone exerts feedback control of the pituitary lh and fsh secretion. depending on the tissues, testosterone can be further converted to dihydrotestosterone or estradiol.
  • Testosterone Congeners

    steroidal compounds related to testosterone, the major mammalian male sex hormone. testosterone congeners include important testosterone precursors in the biosynthetic pathways, metabolites, derivatives, and synthetic steroids with androgenic activities.
  • Testosterone Propionate

    an ester of testosterone with a propionate substitution at the 17-beta position.
  • Zeranol

    a non-steroidal estrogen analog.

Coding Guidelines

When coding a poisoning or reaction to the improper use of a medication (e.g., overdose, wrong substance given or taken in error, wrong route of administration), first assign the appropriate code from categories T36-T50. The poisoning codes have an associated intent as their 5th or 6th character (accidental, intentional self-harm, assault and undetermined. If the intent of the poisoning is unknown or unspecified, code the intent as accidental intent. The undetermined intent is only for use if the documentation in the record specifies that the intent cannot be determined. Use additional code(s) for all manifestations of poisonings.

The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of hormones and their synthetic substitutes and antagonists, not elsewhere classified (T38). Use the following options for the aplicable episode of care:

  • A - initial encounter
  • D - subsequent encounter
  • S - sequela

Convert T38.7X1A to ICD-9-CM

  • ICD-9-CM Code: 962.1 - Poisoning-androgens
    Combination Flag - Multiple codes are needed to describe the source diagnosis code. Correct coding should be done based on contextual judgment.
  • ICD-9-CM Code: E858.0 - Acc poison-hormones
    Combination Flag - Multiple codes are needed to describe the source diagnosis code. Correct coding should be done based on contextual judgment.

Table of Drugs and Chemicals

The parent code T38.7X1 of the current diagnosis code is referenced in the Table of Drugs and Chemicals, this table contains a classification of drugs, industrial solvents, corrosive gases, noxious plants, pesticides, and other toxic agents.

According to ICD-10-CM coding guidelines it is advised to do not code directly from the Table of Drugs and Chemicals, instead always refer back to the Tabular List when doing the initial coding. Each substance in the table is assigned a code according to the poisoning classification and external causes of adverse effects. It is important to use as many codes as necessary to specify all reported drugs, medicinal or chemical substances. If the same diagnosis code describes the causative agent for more than one adverse reaction, poisoning, toxic effect or underdosing, utilize the code only once.

Substance Poisoning
Accidental
(unintentional)
Poisoning
Accidental
(self-harm)
Poisoning
Assault
Poisoning
Undetermined
Adverse
effect
Underdosing
Anabolic steroidT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
AndrogenT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
Androgen-estrogen mixtureT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
AndrostaloneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
AndrostanoloneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
AndrosteroneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
CalusteroneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
Chlorodehydro-methyltestosteroneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
Congener, anabolicT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
DromostanoloneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
DrostanoloneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
DurabolinT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
EpitiostanolT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
EstanozololT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
EthylestrenolT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
FluoxymesteroneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
MacrolideT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
Macrolide
  »anabolic drug
T38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
Macrolide
  »antibiotic
T38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
MepitiostaneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
MestanoloneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
MesteroloneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
MetandienoneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
MetandrostenoloneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
MetenoloneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
MethandienoneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
MethandriolT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
MethandrostenoloneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
MethenoloneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
MethyltestosteroneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
NandroloneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
NorethandroloneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
Nortestosterone (furanpropionate)T38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
OxandroloneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
OxymesteroneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
OxymetholoneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
PrasteroneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
StanoloneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
StanozololT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
TestolactoneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
TestosteroneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
ZeranolT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6

Patient Education


Hormones

Hormones are your body's chemical messengers. They travel in your bloodstream to tissues or organs. They work slowly, over time, and affect many different processes, including:

  • Growth and development
  • Metabolism - how your body gets energy from the foods you eat
  • Sexual function
  • Reproduction
  • Mood

Endocrine glands, which are special groups of cells, make hormones. The major endocrine glands are the pituitary, pineal, thymus, thyroid, adrenal glands, and pancreas. In addition, men produce hormones in their testes and women produce them in their ovaries.

Hormones are powerful. It takes only a tiny amount to cause big changes in cells or even your whole body. That is why too much or too little of a certain hormone can be serious. Laboratory tests can measure the hormone levels in your blood, urine, or saliva. Your health care provider may perform these tests if you have symptoms of a hormone disorder. Home pregnancy tests are similar - they test for pregnancy hormones in your urine.


[Learn More in MedlinePlus]

Medication Errors

Medicines treat infectious diseases, prevent problems from chronic diseases, and ease pain. But medicines can also cause harmful reactions if not used correctly. Errors can happen in the hospital, at the health care provider's office, at the pharmacy, or at home. You can help prevent errors by:

  • Knowing your medicines. When you get a prescription, ask the name of the medicine and check to make sure that the pharmacy gave you the right medicine. Make sure that you understand how often you should take the medicine and how long you should take it.
  • Keeping a list of medicines.
    • Write down all of the medicines that you are taking, including the names of your medicines, how much you take, and when you take them. Make sure to include any over-the-counter medicines, vitamins, supplements, and herbs that you take.
    • List the medicines that you are allergic to or that have caused you problems in the past.
    • Take this list with you every time you see a health care provider.
  • Reading medicine labels and following the directions. Don't just rely on your memory - read the medication label every time. Be especially careful when giving medicines to children.
  • Asking questions. If you don't know the answers to these questions, ask your health care provider or pharmacist:
    • Why am I taking this medicine?
    • What are the common side effects?
    • What should I do if I have side effects?
    • When should I stop this medicine?
    • Can I take this medicine with the other medicines and supplements on my list?
    • Do I need to avoid certain foods or alcohol while taking this medicine?

Food and Drug Administration


[Learn More in MedlinePlus]

Code History

  • FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
  • FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
  • FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.

Footnotes

[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.